Evidence map›Paper›PMID 27895997›Full record

ArticleBiomedical optics express2016

Thermal therapy with magnetic nanoparticles for cell destruction.

Adi Vegerhof, Menachem Motei, Arkady Rudinzky, Dror Malka, Rachela Popovtzer, Zeev Zalevsky

Abstract read
In one paragraph

Article in Biomedical optics express, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Nanotechnology against COVID-19: Immunization, diagnostic and therapeutic studies.Journal of controlled release : official journal of the Controlled Release Society · 2021
    Review
  3. Review
  4. Review
  5. Fe/Mn Multilayer Nanowires as High-Performance TMaterials (Basel, Switzerland) · 2021
    Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Adi VegerhofFaculty of Engineering & the Institute of Nanotechnology and Advanced Materials, Bar-Ilan University, Ramat-Gan, Israel.
Menachem MoteiFaculty of Engineering & the Institute of Nanotechnology and Advanced Materials, Bar-Ilan University, Ramat-Gan, Israel.
Arkady RudinzkyFaculty of Engineering & the Institute of Nanotechnology and Advanced Materials, Bar-Ilan University, Ramat-Gan, Israel.
Dror MalkaFaculty of Engineering Holon Institute of Technology, Holon, Israel.
Rachela PopovtzerFaculty of Engineering & the Institute of Nanotechnology and Advanced Materials, Bar-Ilan University, Ramat-Gan, Israel.
Zeev ZalevskyFaculty of Engineering & the Institute of Nanotechnology and Advanced Materials, Bar-Ilan University, Ramat-Gan, Israel.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this article we suggest a new concept for cell destruction based upon manipulating magnetic nanoparticles (MNPs) by applying external, low frequency alternating magnetic field (AMF) that oscillates the particles, together with focused laser illumination. Assessment of temperature profiles in a head and neck squamous cell carcinoma sample showed that cells with MNPs, treated with AMF (3 Hz, 300 mW) and laser irradiation (30 mW), reached 42°C after 4.5 min, as opposed to cells treated with laser but without AMF. Moreover, a theoretical model was developed to assess the overall theoretical temperature rise, which was shown to be 50% lower than the experimental temperature. Furthermore, we found that the combination of laser irradiation and AMF decreased the number of live cells by ~50%. Thus, the concentrated assembly of laser heating with AMF-induced MNP oscillations leads to more rapid and efficient cell death. These results suggest that the manipulated MNP technique can serve as a superior agent for PTT, with improved cell death capabilities.

Indexed as

(140.3538) Lasers, pulsed(140.7300) Visible lasers(170.1420) Biology(170.1470) Blood or tissue constituent monitoring(170.1530) Cell analysis

Identifiers

PMID27895997
PMCPMC5119597

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.